BlackRock Fund Advisors’s Plus Therapeutics PSTV Stock Holding History

BlackRock Fund Advisors’s Portfolio PSTV Stock Details PSTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Hold	0	–	–	–	3694
2016 Q3	–	Hold	0	–	–	–	3702
2016 Q2	–	Hold	0	–	–	–	3754
2016 Q1	–	Hold	0	–	–	–	4033
2015 Q4	–	Hold	0	–	–	–	4133
2015 Q2	–	Sell	-1	Closed	-$2.65M	–	3892
2015 Q1	$2.65M	Hold	1	–	–	﹤0.01%	3077
2014 Q4	$920K	Hold	1	–	–	﹤0.01%	3228
2014 Q3	$1.1M	Hold	1	–	–	﹤0.01%	3189
2014 Q2	$3.97M	Hold	1	–	–	﹤0.01%	2957
2014 Q1	$4.83M	Hold	1	–	–	﹤0.01%	2840
2013 Q4	$4.49M	Hold	1	–	–	﹤0.01%	2892
2013 Q3	$5.96M	Hold	1	–	–	﹤0.01%	2679
2013 Q2	$5.18M	Buy	+1	New	+$7M	﹤0.01%	2662

Other funds holding PSTV

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock Fund Advisors's PSTV Position: Q4 2016 in Review

BlackRock Fund Advisors held its Plus Therapeutics (PSTV) position steady in Q4 2016 at 0 shares worth $67K. The position accounts for ﹤0.01% of the portfolio, ranked #3694.

BlackRock Fund Advisors first reported a position in PSTV in Q2 2013 and has held it in 8 quarters since. The position peaked at $5.96M in Q3 2013. 4 funds tracked by Wall St. Rank hold PSTV as of Q4 2016.

BlackRock Fund Advisors held 0 shares of Plus Therapeutics worth $67K as of Q4 2016.
BlackRock Fund Advisors left its Plus Therapeutics share count unchanged in Q4 2016.
Plus Therapeutics made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3694 holding.
BlackRock Fund Advisors first reported a position in Plus Therapeutics in Q2 2013 and has held it in 8 quarters since.
BlackRock Fund Advisors's Plus Therapeutics position peaked at $5.96M in Q3 2013.
4 funds tracked by Wall St. Rank held Plus Therapeutics as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.